News
Merck reports positive results from the first two phase 3 CORALreef trials of enlicitide decanoate to treat adults with hyperlipidemia: Rahway, New Jersey Tuesday, June 10, 2025, ...
CII Telangana to hold ‘Pillars of Protection’ conference on pharma & chemical industries safety on June 25 at Hyderabad: Our Bureau, Bengaluru Tuesday, June 10, 2025, 09:00 Hr ...
Experts support Centre’s ban on medical representatives from Central govt hospitals for sales promotion: Shardul Nautiyal, Mumbai Tuesday, June 10, 2025, 08:00 Hrs [IST] Followi ...
Peethaambaran Kunnathoor, Chennai Tuesday, June 10, 2025, 08:00 Hrs [IST] ...
Hospitals work on data protection for responsible patient care: Dr Sameer Bhati: Nandita Vijayasimha, Bengaluru Tuesday, June 10, 2025, 08:00 Hrs [IST] Healthcare systems are incr ...
The leading 30 pharmaceutical companies, with revenues above Rs 2,500 crore, have registered robust net profit growth of 31 per cent during the financial year 2024-25 on account of new product ...
CDSCO, DAHD to form JWG to monitor use of antimicrobials in animals: Gireesh Babu, New Delhi Tuesday, June 10, 2025, 08:00 Hrs [IST] In an effort to control the use of antimicrobi ...
MEDSIR announces positive results from TUXEDO-3 trial of patritumab deruxtecan in patients with active brain metastases and leptomeningeal disease: Chicago Monday, June 9, 2025, 1 ...
Biocon Foundation with NCBS & BeST Cluster launches BioWISE Programme to empower women in STEM: Our Bureau, Bengaluru Monday, ...
DHN unveils landmark Annual Digital Health Trends & Outlook 2025 Report at its Delhi Forum; AI emerges as top priority: Our ...
US FDA clears YolTech’s IND application for YOLT-101, an in vivo base editing therapy to treat heterozygous familial hypercholesterolemia: Shanghai, China Monday, June 9, 2025, ...
CK Birla Hospital strengthens robotic orthopaedics programme amid rising burden of joint issues in India: Our Bureau, Bengaluru Monday, June 9, 2025, 16:45 Hrs [IST] CK Birla Hosp ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results